secwatch.observer — SEC 8-K summary
======================================

Issuer:     HEALTHEQUITY, INC. (HQY)
CIK:        0001428336
Form:       8-K
Filed at:   2022-12-06T23:59:59+00:00
Accession:  0001428336-22-000031
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HealthEquity Q3 revenue $216.1M (+20% YoY); narrows net loss; guides FY2024 ~$950-970M
--------------------------------------------------------------------------------

- Revenue $216.1M (+20% YoY); net loss $1.6M vs $5.0M loss; non-GAAP diluted EPS $0.38 vs $0.35.
- Adjusted EBITDA $73.4M (+20%); margin 34%; HSAs 7.7M (+23%); total accounts 14.5M (+9%).
- FY2023 outlook: revenue $850-860M; Adj EBITDA $261-271M; non-GAAP EPS $1.26-$1.35.
- FY2024 initial guidance: revenue ~$950-970M; Adj EBITDA margin ~33-34%; assumes ~2.25% cash yield.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1428336/000142833622000031/0001428336-22-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1428336/000142833622000031/hqy-20221206.htm
  HTML page:      https://secwatch.observer/filing/0001428336-22-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer